Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
25.20
-0.30 (-1.18%)
Sep 10, 2026, 3:00 PM CST

SHA:603351 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
154.99150.97146.42112.295.03101.37
Depreciation & Amortization
130.97132.11116.0771.7471.7642.81
Other Amortization
1.320.860.091.031.11.13
Loss (Gain) From Sale of Assets
-0.01-0.02--00.05
Asset Writedown & Restructuring Costs
0.40.420.170.180.11.91
Loss (Gain) From Sale of Investments
-1.58-3.44-12-1.440.11-2.25
Provision & Write-off of Bad Debts
0.730.360.340.29-4.482.35
Other Operating Activities
18.0615.5620.2814.2612.216.17
Change in Accounts Receivable
-394.62-414.81-13.57-31.4134.17-105.72
Change in Inventory
-6.16-10.12-40.46-9.38-22.77-29.18
Change in Accounts Payable
352.53365.19-3.98-43.96-106.45-42.06
Change in Other Net Operating Assets
-2.43-2.433.3610.4628.0615.44
Operating Cash Flow
258.02238.24221.79120.24108.99-11.54
Operating Cash Flow Growth
17.74%7.42%84.45%10.33%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-50.16-52.18-51.46-73.07-233.9-235.62
Sale of Property, Plant & Equipment
0.220.22----
Investment in Securities
7.07-22.12-18.535.23-4.73172.72
Other Investing Activities
-0.250.02-0.5-0.95-5.07
Investing Cash Flow
-59.75-74.06-70.48-67.84-237.68-67.97

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-551381.02483.15480.87220.06
Total Debt Issued
442551381.02483.15480.87220.06
Long-Term Debt Repaid
--472.81-387.19-434.1-268.19-157.47
Lease Payments
-11.42-11.49-8.89-8.68-6.73-2.76
Total Debt Repaid
-591.94-472.81-387.19-434.1-268.19-157.47
Net Debt Issued (Repaid)
-149.9478.19-6.1649.05212.6862.59
Issuance of Common Stock
-----49.27
Common Dividends Paid
-92.22-64.89-55.47-53.41-53.89-45.25
Other Financing Activities
---1.49.162.43.95
Financing Cash Flow
-242.1613.3-63.034.79161.270.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-3.21-0.831.370.531.06-0.36
Net Cash Flow
-47.08176.6689.6557.7233.56-9.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
207.86186.07170.3447.17-124.91-247.16
Free Cash Flow Growth
33.28%9.23%261.09%---
Free Cash Flow Margin
14.84%13.94%13.14%4.08%-11.24%-23.71%
Free Cash Flow Per Share
1.531.371.260.35-0.93-1.85
Levered Free Cash Flow
192.14197.94122.94-23.51-90.86-214.39
Unlevered Free Cash Flow
199.1204.62131.58-13.98-83.05-209.99
Free Cash Flow After Leases
196.44174.58161.4538.49-131.65-249.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
70.8966.6670.0952.21-2.9925.21
Change in Working Capital
-46.86-58.58-49.56-78.01-66.84-165.09